Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Douglas G. Altman

24 ta ish

University of Oxford

AkademScholarda batafsil koʻrsatkichlar

  1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

    David Moher, Alessandro Liberati, Jennifer Tetzlaff +2

    MaqolaOchiq kirish200919 iqtibos
    ABI

  2. Measuring inconsistency in meta-analyses

    Julian P. T. Higgins, Simon G. Thompson, Jonathan J Deeks +1

    Sharh maqolaOchiq kirish200314 iqtibos
    ABI

  3. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

    Erik von Elm, Douglas G. Altman, Matthias Egger +3

    MaqolaOchiq kirish200714 iqtibos
    ABI

  4. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

    David Moher, A. Liberati, Jennifer Tetzlaff +2

    MaqolaOchiq kirish20099 iqtibos
    ABI

  5. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

    Jonathan A C Sterne, Miguel A. Hernán, Barnaby C Reeves +32

    MaqolaOchiq kirish20167 iqtibos
    ABI

  6. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

    David Moher, Alessandro Liberati, Jennifer Tetzlaff +1

    Maqola20106 iqtibos
    ABI

  7. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies

    Erik von Elm, Douglas G. Altman, Matthias Egger +4

    MaqolaOchiq kirish20076 iqtibos
    ABI

  8. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

    Alessandro Liberati, Douglas G. Altman, Jennifer Tetzlaff +7

    Sharh maqolaOchiq kirish20095 iqtibos
    ABI

  9. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

    Erik von Elm, Douglas G. Altman, Matthias Egger +3

    Maqola20085 iqtibos
    ABI

  10. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations

    Sander Greenland, Stephen Senn, Kenneth J. Rothman +4

    Maqola20164 iqtibos
    ABI

  11. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration

    Jan P. Vandenbroucke, Erik von Elm, Douglas G. Altman +7

    MaqolaOchiq kirish20073 iqtibos
    ABI

  12. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

    David Moher, Alessandro Liberati, Jennifer Tetzlaff +1

    MaqolaOchiq kirish20093 iqtibos
    ABI

  13. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies

    Erik von Elm, Douglas G. Altman, Matthias Egger +4

    Maqola20073 iqtibos
    ABI

  14. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies

    Erik von Elm, Douglas G. Altman, Matthias Egger +3

    MaqolaOchiq kirish20143 iqtibos
    ABI

  15. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration

    Jan P. Vandenbroucke, Erik von Elm, Douglas G. Altman +6

    MaqolaOchiq kirish20142 iqtibos
    ABI

  16. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

    Jonathan A C Sterne, Alex J. Sutton, John P. A. Ioannidis +16

    MaqolaOchiq kirish20112 iqtibos
    ABI

  17. Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2

    Gary S. Collins, Douglas G. Altman

    MaqolaOchiq kirish20122 iqtibos
    ABI

  18. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

    Alessandro Liberati, Douglas G. Altman, Jennifer Tetzlaff +7

    MaqolaOchiq kirish20092 iqtibos
    ABI

  19. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

    the CONSORT Group, Kenneth F. Schulz, Douglas G. Altman +1

    Maqola20102 iqtibos
    ABI

  20. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

    John G.F. Cleland, Karina V Bunting, Marcus Flather +19

    Sharh maqola20172 iqtibos
    ABI

  21. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies

    Patrick M. Bossuyt, Johannes B. Reitsma, David E. Bruns +15

    Maqola20152 iqtibos
    ABI

  22. The logrank test

    Martin Bland, Douglas G. Altman

    Sharh maqola20042 iqtibos
    ABI

  23. Reprint—Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

    David Moher, Alessandro Liberati, Jennifer Tetzlaff +2

    Maqola20092 iqtibos
    ABI

  24. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

    Erik von Elm, Douglas G. Altman, Matthias Egger +3

    Maqola20072 iqtibos
    ABI